Oculis Holding AG (OCS) EPS (Basic) (2022 - 2026)
Oculis Holding AG's (OCS) quarterly EPS (Basic) came in at -$0.0 in Q1 2026, up 29.25% year-on-year from -$0.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$0.0 in Q4 2025.
Oculis Holding AG (OCS) EPS (Basic) (2022 - 2026) Analysis & Trends
Oculis Holding AG's EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.0 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 29.25% year-over-year to -$0.0 in Q1 2026; TTM through Mar 2026 was -$0.0, a 29.83% increase from a year earlier, with the FY2025 full-year figure at -$0.0, up 26.84% from the prior year.
- EPS (Basic) advanced to -$0.0 in Q1 2026 per OCS's latest filing, from -$0.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.0 in Q1 2026 and bottomed at -$0.0 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.0 (2025), against an average of -$0.0.
- Across the five-year window, EPS (Basic) soared 98.97% in 2023 and slumped 47.65% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$0.0 in 2022, then soared by 98.59% to -$0.0 in 2023, then slumped by 47.65% to -$0.0 in 2024, then surged by 46.86% to -$0.0 in 2025, then jumped by 100.0% to -$0.0 in 2026.
- Per Business Quant, the three latest OCS EPS (Basic) figures stand at -$0.0 (Q1 2026), -$0.0 (Q4 2025), and -$0.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 1.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |